baber/WOPTO huggingface dataset:
Patent AU-6457200-A (AU)
Title: Global motion estimation and compensation in video compression
Inventor: MONRO DONALD MARTIN
IPC: H04N7/26
Filed: 2000-08-08
Abstract: A method of video motion estimation is described for determining the dominant motion in a video image. The dominant motion is defined by a parametric transform, for example a similarity transform. In the preferred embodiment, selected pairs of blocks in one frame are traced by a block matching algorithm into a subsequent frame, and their change in position determined. From that information, an individual parameter estimate is determined. The process is repeated for many pairs of blocks, to create a large number of parameter estimates. These estimates are then sorted into an ordered list, the list is preferably differentiated, and the best global value for the parameter is determined from the differentiated list. One approach is to take the minimum value of the differentiated list, selected from the longest run of values which fall below a threshold value. Alternatively, the ordered list may be examined for flat areas, without explicit differentiation. The technique is particularly suited to low complexity, low bit rate multimedia applications, where reasonable fidelity is required without the computational overhead of full motion compensation.
Patent AU-6527000-A (AU)
Title: Tubular graft construct
Inventor: FEARNOT NEAL E
IPC: A61F2/92
Filed: 2000-08-07
Abstract: Described are medical devices which are or can be used to form tubular medical devices, and related methods. Preferred devices include tubular grafts of biomaterial having lumen walls which present no seam edge that traverses the entire length of the lumen, illustratively including devices having lumen walls which have a discontinuous seam presenting multiple seam edges. Such a device may include a tubular structure formed by inserting a plurality of extensions of a biomaterial sheet through a plurality of corresponding apertures of the sheet.
Patent AU-6530301-A (AU)
Title: Low nitrogen oxides emissions using three stages of fuel oxidation and in-situ furnace flue gas recirculation
Inventor: ASHWORTH ROBERT A
IPC: F23L9/02
Filed: 2001-06-01
Abstract: A method for reducing NOx emissions from the combustion of carbonaceous fuels using three stages of oxidation and second stage in-situ furnace flue gas recirculation. In the first stage, a partial oxidation combustor is used to partially combust the fuel in the presence of preheated combustion air. The fuel gas produced in the partial oxidation process is passed to a second stage partial oxidation combustor while molten slag is removed and disposed of. Preheated combustion air also is introduced into the second stage of combustion to produce a slightly reducing flue gas and is injected into the furnace in such a way as to create the desired in-situ furnace flue gas recirculation. In the upper part of the furnace a third combustion air is mixed with the flue gas in a third stage of combustion to substantially complete the combustion process. Preheated steam may be added to the first or second stages of combustion. The stoichiometric ratios at each stage of combustion are controlled to minimize overall NOx emissions to acceptable levels. Further, an existing excess air cyclone-fired boiler furnace may be modified to operate in a three-stage combustion mode. This is accomplished by adding a preheated air system that includes two added air injection points into the furnace, with air introduction at a cyclone barrel re-entrant throat that is located at the interface between the cyclone barrel and the furnace, followed by overfire air introduction into the upper part of the furnace.
Patent AU-6643494-A (AU)
Title: Modification of implant surface with bioactive conjugates for improved integration
Inventor: NANCI ANTONIO
IPC: A61L27/28
Filed: 1994-05-09
Abstract: The present invention relates to a bioactive conjugate adapted to coat a metal implant outer surface, which have the following structural formula (I): -R-X-P wherein, R is O or S, adapted to be covalently attached to an implant surface; X is selected from a bond, linear or branched chains of 1 to 30 covalently attached atoms of at least C, N, O, Si or S, rings of 1 to 20 covalently attached atoms of at least C, N, O, Si or S, and a combination thereof; and P is a bioactive molecular moiety which promotes tissue growth, stabilization and integration, and wherein said moiety retains its biological activity. The present invention also relates to a process for the covalent coating of implants with bioactive conjugates.
Patent AU-6685000-A (AU)
Title: Method for automatically adapting to the capabilities of a data transmitting terminal a device supplying data to said terminal requesting the data
Inventor: HILLEBRAND RAINER
IPC: G06T1/00
Filed: 2000-07-26
Abstract: A method for automatically adapting to the capabilities of a data transmitting terminal a device supplying data to said terminal requesting the data. The method is characterized in that the data supplying device receives information concerning the capabilities of the device requesting data to send to the latter the data to be transmitted in accordance with the specified capabilities.
Patent AU-6720498-A (AU)
Title: Nimesulide topical formulations in the form of liquid crystals
Inventor: BADER STEFANO
IPC: A61K31/18
Filed: 1998-02-17
Abstract: Nimesulide topical formulations are provided in the form of liquid crystals. The emulsifier cetylstearyl glycoside is used, and constituents of the lipid phase such as caprylic/capric triglycerides and jojoba oil, consistence factors such as cetylstearyl alcohol. Also disclosed is a process for the preparation thereof. The formulations have advantages such as higher stability, better release and absorption of nimesulide, and a higher bioavailability of the active ingredient.
Patent AU-6749298-A (AU)
Title: Process for the production of synthesis gas
Inventor: YAGI FUYUKI
IPC: C01B32/40
Filed: 1998-04-13
Abstract: Disclosed is a process for producing a synthesis gas by reacting a carbon-containing organic compound with steam and/or carbon dioxide using a catalyst whose carbon deposition activity is considerably suppressed. The catalyst is characterized in that it comprises a carrier formed of a metal oxide, and at least one catalytic metal selected from rhodium, ruthenium, iridium, palladium and platinum and supported on the carrier, in that the catalyst has a specific surface area of 25 m<2>/g or less, in that the electronegativity of the metal ion of the carrier metal oxide is 13.0 or less and in that the amount of the catalytic metal is 0.0005-0.1 mole %, in terms of metal, based on the carrier metal oxide.
Patent AU-6794594-A (AU)
Title: Antisense-oligonucleotides for the treatment of immunosuppressive effects of transforming growth factor-beta (tgf-beta )
Inventor: SCHLINGENSIEPEN GEORG-FERDINAN
IPC: C12N15/09
Filed: 1994-04-29
Abstract: Antisense-oligonucleotides or effective derivatives thereof hybridizing with an area of a gene coding for transforming growth factor-β (TGF-β) comprising the following nucleic acid sequences identified in the sequence listing under SEQ ID NO. 1-56 and 137 or comprising the following nucleic acid sequences identified in the sequence listing under SEQ ID NO. 57 to 136 each of the nucleic acids having a DNA- or RNA-type structure.
Patent AU-6807700-A (AU)
Title: Plasmids from corynebacterium glutamicum and use thereof
Inventor: TAUCH ANDREAS
IPC: C12N15/77
Filed: 2000-10-25
Abstract: The mutually compatible plasmids pTET3 and pCRY4, isolated from Corynebacterium glutamicum DSM 5816 are new. pTET3 contains about 27.8 kb; includes a replication region of 4539 bp (1) and a 7136 bp antibiotic resistance region (6) containing the tetA gene (resistance to tetracycline) and the aadA gene (resistance to streptomycin and spectinomycin. pCRY4 contains about 48 kp and includes a replication region of 1856 bp (4). Restriction maps and sequences for (1), (4) and (6) are reproduced. Independent claims are also included for the following: (a) composite plasmid (CP1) for autonomic replication in corynefrom bacteria containing at least part of the nucleic acid sequences of these plasmids; at least one replication region derived from pTET3 or pCRY4; a replicable gene fragment from Escherichia coli, Bacillus subtilis or Streptomyces, and at least one region for expression of resistance; (b) composite plasmid (CP2) for autonomic replication in corynefrom bacteria containing at least one replication region from pGA1, pGA2, pTET3 or pCRY4; at least one resistance from pTET3 and optionally at least one DNA fragment that encodes a protein involved in biosynthesis of a vitamin, nucleotide or L-amino acid and is expressible in coryneforms; (c) plasmid vectors pSELF3-1 (about 7 kb) and pSELF1-1 (about 7.3 kb) (restriction maps reproduced); (d) production of L-amino acids (particularly lysine or threonine) by culturing a coryneform strain that contains at least one of CP1, CP2 or pSELF3-1; and (e) production of vitamins, especially D-panthothenic acid, by culturing a coryneform strain that contains at least one of pSELF3-1 or pSELF1-1.
Patent AU-6823494-A (AU)
Title: Medical probe device with optic viewing capability
Inventor: EDWARDS STUART D
IPC: A61N1/40
Filed: 1994-05-12
Abstract: A medical probe device comprising a catheter having a stylet guide housing with at least one stylet port in a side thereof and stylet guide means for directing a flexible stylet outward through at least one stylet port and through intervening tissue to targeted tissues. The stylet guide housing has an optical viewing means positioned for viewing the stylet and adjacent structure which includes a fiber optic channel means for receiving a fiber optic viewing device. The fiber optic channel means can include a guide port means for directing longitudinal movement of a fiber optic device with respect to the stylet guide means in a viewing zone and a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across the end of a fiber optic device when positioned in the viewing zone. The optical viewing means can comprise a viewing window positioned in the stylet guide housing for viewing the stylet when it is directed outward from its respective stylet port. The optical viewing means can include a fiber optic channel in the stylet guide housing for receiving the a fiber optic viewing device and aligning the viewing end thereof with the viewing window. Windowed devices can include a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across a surface of the viewing window. <IMAGE>
Patent AU-6915594-A (AU)
Title: Permanent magnet coupling
Inventor: LAMB KARL J
IPC: H02K49/10
Filed: 1994-05-16
Abstract: A magnetic coupler has a magnetic disc containing permanent magnets located between two electroconductive plates and separated therefrom by air gaps. The magnetic disc and electroconductive plates are mounted on coaxial or parallel-spaced input and output shafts so that rotation of the input shaft causes rotation of the output shaft by way of magnetic friction between the permanent magnets and the electroconductive plates.
Patent AU-7079494-A (AU)
Title: Energy storage and conversion devices
Inventor: JENNINGS HOWARD TIMOTHY
IPC: H02K11/00
Filed: 1994-07-06
Abstract: A flywheel energy storage and conversion apparatus (1) comprising a stator (5), a rotor (7) incorporating an optical fibre (17), a light source (19) and a detector (21), wherein the optical fibre (17) is carried by rotor (7) such that a light beam can be passed along the optical fibre (17) from the light source (19) to the detector (21) during rotation of the rotor (7) to deliver information to the detector (21) indicative of a characteristic of the rotor (7). Such an apparatus provides information regarding the status of the rotor such that the complete apparatus can be shut down immediately if the rotor appears to be about to disintegrate.
Patent AU-7174691-A (AU)
Title: Magnetically responsive fluorescent polymer particles and application thereof
Inventor: WANG CHAO-HUEI J
IPC: G01N33/58
Filed: 1990-12-12
Abstract: This invention provides a novel process of producing magnetically responsive fluorescent polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used as core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive fluorescent polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
Patent AU-7263991-A (AU)
Title: 3-tetrazolylthiomethyl cephalosporin antibiotics
Inventor: JUNG FREDERICK HENRI
IPC: A61P31/04
Filed: 1991-03-06
Abstract: A compound of the formula (II): <CHEM> and pharmaceutically acceptable salts and in vivo hydrolysable esters are described as is their preparation and use as antibacterial agents.
Patent AU-7352196-A (AU)
Title: Arrangement in electronically controlled injection devices
Inventor: HJERTMAN BIRGER
IPC: A61M5/178
Filed: 1996-10-14
Abstract: In an electronically controlled injection device for the administering of one or more injections from an injection cartridge (1), the readying of the device for administering and the subsequent administering therefrom are controlled by an electronic control unit (7). This control unit (7) comprises a position or attitude sensor (8) which transmits signals to the control unit (7) such that said readying of the device cannot take place unless the longitudinal axis of the injection cartridge (1) is oriented in a predetermined direction.
Patent AU-7608400-A (AU)
Title: Apparatus for swaging ferrules
Inventor: JOHNSTON LONNIE E
IPC: B21J9/06
Filed: 2000-09-22
Abstract: Apparatus for swaging a ferrule or ferrules onto an outer wall of a cylindrical member includes a hydraulic power section and an adapter tool. The hydraulic section is disposed within a housing, and the adapter tool is at least partly retained in the housing and also is fully removable from the housing without affecting the hydraulic power section of the apparatus. The hydraulic section includes a piston that is moved under force of hydraulic pressure applied thereto from a hydraulic pressure source. The adapter tool includes a driven swaging die that is moved from a retracted position to an extended position in response to movement of the piston. The sleeve and anvil are releasably secured together so that the adapter tool can be removed from the housing as a unitary assembly. Size changes can be accommodated by removing a first adapter tool of a given size and replacing it with a second adapter tool of a different size. This changeover can be implemented without any disassembly or compromise of the hydraulic section. The apparatus also provide a visual indication that a swaging operation is completed by action of an indicator knob that axially pops out of the back end of the housing at the end of a swaging operation.
Patent AU-7652101-A (AU)
Title: Cinnoline compounds
IPC: A61P19/02
Filed: 2001-08-07
Abstract: The invention relatest to compounds of the formula (I) wherein either any one of G<SUB>1</SUB>, G<SUB>2</SUB>, G<SUB>3</SUB>, G<SUB>4 </SUB>and G<SUB>5 </SUB>is nitrogen and the other four are -CH-, or G<SUB>1</SUB>, G<SUB>2</SUB>, G<SUB>3</SUB>, G<SUB>4 </SUB>and G<SUB>5 </SUB>are all -CH-; Z is -O-, -NH-, -S-, -CH<SUB>2</SUB>- or a direct bond; Z is linked to any one of G<SUB>1</SUB>, G<SUB>2</SUB>, G<SUB>3 </SUB>and G<SUB>4 </SUB>which is a free carbon atom; n is an integer from 0 to 5; any of the substitutents R<SUP>1 </SUP>may be attached at any free carbon atom of the indole, azaindole or indazole group; m is an integer from 0 to 3; R<SUP>a </SUP>represents hydrogen; R<SUP>b </SUP>represents hydrogen or another value as defined herein; R<SUP>1 </SUP>represents hydrogen, oxo, hydroxy, halogeno, C<SUB>1-4</SUB>alkyl, C<SUB>1-4</SUB>alkoxy, C<SUB>1-4</SUB>alkoxy, C<SUB>1-4</SUB>-alkyl, aminoC<SUB>1-4</SUB>alkyl, C<SUB>1-3</SUB>alkylaminoC<SUB>1-4</SUB>alkyl, di(C<SUB>1-3</SUB>alkyl)aminoC<SUB>1-4</SUB>alkyl, -C<SUB>1-5</SUB>alkyl(ring B) wherein ring B is selected from azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, N-methylpiperazinly, N-ethylpiperazinyl, morpholino and thiomorpholino; R<SUP>2 </SUP>represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C<SUB>1-3</SUB>alkyl, C<SUB>1-3</SUB>alkoxy, C<SUB>1-3</SUB>aklylsulphanyl, -NR<SUP>3</SUP>R<SUP>4 </SUP>(wherein R<SUP>3 </SUP>and R<SUP>4</SUP>, which may be the same or different, each represents hydrogen or C<SUB>1-3</SUB>alkyl), or R<SUP>5</SUP>X<SUP>1</SUP>- (wherein R<SUP>5 </SUP>and X<SUP>1 </SUP>are as defined herein) and salts thereof, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient and the use of a compound of formula I in the manufacture of medicament for the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent AU-7777600-A (AU)
Title: Air conditioning unit with an inner heat transfer unit
Inventor: DIENHART BERND
IPC: F25B43/00
Filed: 2000-09-18
Abstract: The invention relates to an air conditioning unit with a coolant circuit which consists of a compressor, an evaporator, a collector located at the low pressure side between the evaporator and the compressor and an inner heat transfer unit with a beat transfer channel located at the high pressure side and a low pressure side beat transfer channel. According to the invention, the inner heat transfer unit has an at least segmentally spiraling and/or spiral-shaped steps between the outer and inner pipe of a coaxial pipe system. Additionally or alternatively, the inner heat transfer unit contains a multiple channel line which surrounds the collector in a spiral fashion and/or in which a low pressure side pipe longitudinal channel has a first segment which exits into said collector housing and a second segment which exits out of the said collector housing in addition to a high-pressure side pipe longitudinal channel which traverses the collector housing or leads into a first segment in a high-pressure execution chamber of said collector housing and a second segment leads out of the said chamber. Said invention can be used as a CO2-air conditioning unit in vehicles.
Patent AU-7851201-A (AU)
Title: Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
Inventor: WINTER ERIC
IPC: C07D/
Filed: 2001-07-26
Abstract: The invention relates to a method for the preparation of compound of formula (1). The invention further relates to the previously unknown compounds of formulas (5 and 6) as intermediates in the production of benzodiazepines of formula (1).
Patent AU-8078187-A (AU)
Title: Glycopeptide antibiotics
Inventor: SELVA ENRICO
IPC: C07K/
Filed: 1987-10-08
Abstract: The present invention concerns new antiobiotic substances demoninated de-acyl antibiotics A40926, de-acyl antibiotic A 40926P and antibiotic A 40926 amino glucronyl aglycon, and the use of these substances in the treatment of infectious diseases involving microorganisms susceptible to it.
Patent AU-8288298-A (AU)
Title: Ligand for herpes simplex virus entry mediator and methods of use
Inventor: WARE CARL F
IPC: C12N15/09
Filed: 1998-07-07
Abstract: A novel ligand (p30) for herpes virus entry mediator, HVEM, is provided. p30 is useful for modulating immune responses and in inhibiting infection by herpes virus. Methods for treating subjects with lymphoid cell disorders or those having or suspected of having a herpes virus infection, utilizing p30 of the invention, are also provided.
Patent AU-8773282-A (AU)
Title: Carton blank
Inventor: BILLBERG ALF
IPC: B31B50/20
Filed: 1982-08-26
Abstract: Packing container blanks for gable-top packages are cut out of a material web which, up to now, has caused an appreciable amount of waste material, since the edges of the blanks are irregular and cannot be "dovetailed" into one another. A packing container blank is provided with partly straight, parallel lateral edges (11,12), and partly transverse edges (11,12) which are indented according to a regular pattern which is repeated over the width of the blank. As a result of the indentations, the edges of the blanks too can be formed without wastage.
Patent AU-8827798-A (AU)
Title: Counterpulsation device using noncompressed air
Inventor: SHABTY PAUL
IPC: A61H31/00
Filed: 1998-08-13
Abstract: A counterpulsation device that operates without the use of compressed air or pressurized gas includes at least one inflatable cuff that is adapted to be placed about a selected portion of the patient's body. A first conduit connects the inflatable cuff to an air transfer device so that noncompressed air can be transferred from the air transfer device to the cuff through the first conduit to inflate the cuff. A second conduit connects the cuff to the air transfer device so that air can flow through the second conduit to deflate the cuff. The system is controlled using a computer-based controller that requires a series of initialization procedures before it will operate the system. A patient profile database includes historical treatment data for each patient and is automatically updated with each counter pulsation therapy session.
Patent AU-8869491-A (AU)
Title: Targeted immunostimulation with bispecific reagents
Inventor: ROMET-LEMONNE JEAN LOUP
IPC: A61K47/48
Filed: 1991-10-04
Abstract: Immune response against an antigen is stimulated by administering the antigen in conjunction with a binding agent specific for an antigen-presenting cell such as a macrophage. The binding agent specifically binds a receptor of the antigen-presenting cell, such as an FC receptor, without being blocked by the endogenous ligand for the receptor.
Patent AU-8930591-A (AU)
Title: New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
Inventor: LINDSTEDT BENGT
IPC: A61K47/48
Filed: 1991-12-03
Abstract: A preparation of a pharmacologically active ionizable substance, wherein active substance is ionically complexed to an ion-exchanger resin, which is embedded in a hydrophilid eroding matrix as well as a process for the manufacture thereof.
Patent AU-9066498-A (AU)
Title: Substituted 6-alkylphenanthridines
Inventor: AMSCHLER HERMANN
IPC: A61P17/14
Filed: 1998-07-18
Abstract: Compounds of formula Ipharmaceutically acceptable salts thereof and compositions of either are useful for treating conditions amenable to treatment with a phosphodiesterase inhibitor type 4.
Patent AU-9449998-A (AU)
Title: Composite resonator
Inventor: HUNTER IAN NOEL
IPC: H01P7/10
Filed: 1998-10-14
Abstract: A microwave frequency composite resonator comprising a metal housing having an internal surface and defining a resonator cavity, a dielectric member having a top face and a bottom face and a conducting plate. The dielectric member is located within the resonator cavity and the bottom face of the dielectric member directly abuts the internal surface of the metal housing and the conducting plate directly abuts the top face of the dielectric member.